FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Novocol Pharmaceutical of Canada Scandonest 3% Plain Recall

Scandonest 3% Plain (Mepivacaine Hydrochloride 3% without Vasoconstrictor), packaged in…

Novocol Pharmaceutical of Canada, Inc. · Cambridge, N/A

Risk level
Class III
Reported by FDA
Dec 16, 2020
Recall ID
D-0127-2021
Check your lot numberHow we source this data

Summary

Novocol Pharmaceutical of Canada recalled Scandonest 3% Plain starting Nov 20, 2020. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0127-2021 on Dec 16, 2020. Reason: Labeling: Label mix-up. Status: Terminated.

Why it was recalled

Labeling: Label mix-up

Product description

Scandonest 3% Plain (Mepivacaine Hydrochloride 3% without Vasoconstrictor), packaged in cartons of 50 cartridges (1.7 mL each), Rx only, Manufactured for SEPTODONT, Inc., Louisville, CO 80027, by Novocol Pharmaceutical of Canada, Inc., Cambridge, ON N1R 6X3, Canada, NDC 0362-1098-90

Lot numbers, UPCs & expiration codes

Batch # D03050E, D03032F, Exp 28-Feb-2022; D02983D, Exp 30-Nov-2021; D02865C, Exp 31-Aug-2021; D02894G, Exp 30-Sep-2021; D02701G, Exp 31-Jan-2021; D02766E, Exp 30-Apr-2021

Where it was sold

U.S. nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0127-2021
Classification
Class III
Status
Terminated
Recall initiated
Nov 20, 2020
FDA report date
Dec 16, 2020
Quantity
15,398 cartridges
Recall type
Voluntary: Firm initiated
Recalling firm
Novocol Pharmaceutical of Canada, Inc.

Original FDA data

Every field from FDA enforcement report D-0127-2021, exactly as published.

Show all FDA fields
City
Cambridge
Status
Terminated
Country
Canada
Event ID
86867
Address
25 Wolseley Crt
Code information
Batch # D03050E, D03032F, Exp 28-Feb-2022; D02983D, Exp 30-Nov-2021; D02865C, Exp 31-Aug-2021; D02894G, Exp 30-Sep-2021; D02701G, Exp 31-Jan-2021; D02766E, Exp 30-Apr-2021
Report date
Dec 16, 2020
Product type
Drugs
Recall number
D-0127-2021
Classification
Class III
Recalling firm
Novocol Pharmaceutical of Canada, Inc.
Product quantity
15,398 cartridges
Termination date
May 13, 2021
Reason for recall
Labeling: Label mix-up
Voluntary / mandated
Voluntary: Firm initiated
Product description
Scandonest 3% Plain (Mepivacaine Hydrochloride 3% without Vasoconstrictor), packaged in cartons of 50 cartridges (1.7 mL each), Rx only, Manufactured for SEPTODONT, Inc., Louisville, CO 80027, by Novocol Pharmaceutical of Canada, Inc., Cambridge, ON N1R 6X3, Canada, NDC 0362-1098-90
Distribution pattern
U.S. nationwide.
Recall initiation date
Nov 20, 2020
Initial firm notification
Letter
Center classification date
Dec 9, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0127-2021, published Dec 16, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls